Diabetes and weight loss treatments such as Ozempic and Wegovy, known as GLP-1 agonists, could significantly reduce the risk of developing any type of dementia, according to a meta-analysis of 26 ...

Wegovy is prescribed for weight management and to lower the risk of cardiovascular problems. During the first week of treatment, weight loss is possible, but it may take time to see the full ...

Yet another study is zeroing in on the unintended side effects of Novo Nordisk's semaglutide – the active ingredient in the company's blockbuster weight loss drug Wegovy and diabetes treatment ...

Clinical trials conducted by Novo Nordisk have shown a higher risk of hair loss in patients who took semaglutide compared to those who took a placebo. Wegovy and Ozempic are part of a class of ...

Semaglutide was associated with a 70% reduced risk when compared with insulin. The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy ...

The active ingredient found in popular medications for Type 2 diabetes and weight loss, including Ozempic and Wegovy, may reduce the risk of Alzheimer's disease, a new study published Thursday finds.